Published in AIDS Weekly, October 30th, 2006
"A study was undertaken to assess the frequency of serious (grade III/IV) adverse events and interruption of anti-TB treatment in the era of effective antiretroviral therapy. The incidence of serious adverse events was retrospectively compared in 312 individuals treated for TB, 156 of who were coinfected with HIV."
"One hundred and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.